Science CAR-T Therapies from Cabaletta and Bristol Myers Squibb Show Promise for Autoimmune Disorders Experimental CAR-T therapies developed by Cabaletta Bio and Bristol Myers Squibb have demonstrated the potential to induce complete remissions in patients suffering from severe... Editorial6 hours ago